Dror Ortho-Design, Inc. financial data

Symbol
DROR on OTC
Location
480 Johnson Road, Suite 200, Washington, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 22.9 % -95.7%
Debt-to-equity -129 % -660%
Return On Equity 237 %
Return On Assets -827 % -179%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 957M shares
Common Stock, Shares, Outstanding 957M shares 0%
Entity Public Float 4.31M USD 0%
Common Stock, Value, Issued 95.7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 957M shares +29.6%
Weighted Average Number of Shares Outstanding, Diluted 957M shares +29.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.04M USD -31.2%
General and Administrative Expense 1.43M USD -7.06%
Operating Income (Loss) -2.91M USD +59.4%
Nonoperating Income (Expense) -27.8K USD -182%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.12M USD +54.8%
Net Income (Loss) Attributable to Parent -3.12M USD +54.8%
Earnings Per Share, Basic 0 USD/shares 0%
Earnings Per Share, Diluted 0 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.83M USD +6640%
Other Assets, Current 1.26K USD -77.1%
Assets, Current 251K USD -79.8%
Property, Plant and Equipment, Net 20.4K USD -19.5%
Assets 271K USD -78.6%
Accounts Payable, Current 447K USD +428%
Accrued Liabilities, Current 592 USD +0.34%
Liabilities, Current 2.42M USD +173%
Other Liabilities, Noncurrent 169K USD +3188%
Liabilities 2.59M USD +190%
Retained Earnings (Accumulated Deficit) -21.5M USD -17%
Stockholders' Equity Attributable to Parent -2.32M USD -719%
Liabilities and Equity 271K USD -78.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -500K USD +36%
Net Cash Provided by (Used in) Financing Activities 300K USD
Net Cash Provided by (Used in) Investing Activities -16.7K USD
Common Stock, Shares Authorized 3.25B shares 0%
Common Stock, Shares, Issued 957M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -200K USD +75%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 240K USD -79%
Deferred Tax Assets, Valuation Allowance 11.3M USD +13.8%
Deferred Tax Assets, Gross 11.3M USD +13.8%
Depreciation 1.24K USD +165%
Payments to Acquire Property, Plant, and Equipment 16.7K USD
Deferred Tax Assets, Operating Loss Carryforwards 9.88M USD +6.96%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 12.5M shares 0%
Unrecognized Tax Benefits 2.05M USD
Additional Paid in Capital 19.1M USD +2.31%
Preferred Stock, Shares Outstanding 5.85M shares 0%
Deferred Tax Assets, Net of Valuation Allowance 9.95M USD +374%
Share-based Payment Arrangement, Expense 2.25M USD -0.34%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%